Identifying Age‐Modulating Compounds Using a Novel Computational Framework for Evaluating Transcriptional Age
Aging Cell · 2025-07 · 24 (7)
DOI: 10.1111/acel.70075 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, online erschienen am 30.04.2025. Verfasst von Chao Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Section of Computational Biomedicine, Boston University School of Medicine, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Aging, Pluripotent Stem Cells, Cellular Senescence, Computational Biology. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Starr Foundation, NCI NIH HHS, NIH HHS.
Abstract (Originalsprache)
The differentiation of human pluripotent stem cells (hPSCs) provides access to a wide range of cell types and tissues. However, hPSC‐derived lineages typically represent a fetal stage of development, and methods to expedite the transition to an aged identity to improve modeling of late‐onset disease are limited. In this study, we introduce RNAge, a transcriptome‐based computational platform designed to enable the evaluation of an induced aging or a rejuvenated state. We validated this approach across independent datasets spanning different tissues and species, and show that it can be used to evaluate the effectiveness of existing age‐retaining or age‐modulating interventions. We also used RNAge to perform an in silico compound screen using the LINCS L1000 dataset. This approach led to the identification and experimental confirmation of several novel compounds capable of inducing aging or rejuvenation in primary fibroblasts or hPSC‐derived neurons. Additionally, we observed that applying this novel induced aging strategy to an hPSC model of Alzheimer's disease (AD) accelerated neurodegeneration in a genotype‐specific manner. Our study offers a robust method for quantifying age‐related manipulations and unveils compounds that significantly broaden the toolkit for age‐modifying strategies in hPSC‐derived lineages.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Section of Computational Biomedicine, Boston University School of Medicine, Boston, Massachusetts, USA.
- Institute for Computational Biomedicine, Weill Cornell Medicine, New York, New York, USA.
- Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
- The Center for Stem Cell Biology, Sloan-Kettering Institute for Cancer Research, New York, New York, USA.
- Developmental Biology Program, Sloan-Kettering Institute for Cancer Research, New York, New York, USA.
- Weill Graduate School of Medical Sciences of Cornell University, New York, New York, USA.
ORCID-Profile: Chao Zhang, Nathalie Saurat, Lorenz Studer, Doron Betel
Förderung
- Starr Foundation
- NCI NIH HHS
- NIH HHS
- Glenn Foundation for Medical Research
- NIA NIH HHS
- NCATS NIH HHS
- National Institutes of Health
- National Institute on Aging
Zitieren
APA
Zhang, C., Saurat, N., Cornacchia, D., Chung, S. Y., Sikder, T., Nemchik, A., Minotti, A., Studer, L., & Betel, D. (2025). Identifying Age‐Modulating Compounds Using a Novel Computational Framework for Evaluating Transcriptional Age. Aging Cell, 24(7). https://doi.org/10.1111/acel.70075
Vancouver
Zhang C, Saurat N, Cornacchia D, Chung SY, Sikder T, Nemchik A, et al. Identifying Age‐Modulating Compounds Using a Novel Computational Framework for Evaluating Transcriptional Age. Aging Cell. 2025;24(7). doi:10.1111/acel.70075
BibTeX
@article{Zhang2025,
author = {Zhang, Chao and Saurat, Nathalie and Cornacchia, Daniela and Chung, Sun Young and Sikder, Trisha and Nemchik, Adrianne and Minotti, Andrew and Studer, Lorenz and Betel, Doron},
title = {Identifying Age‐Modulating Compounds Using a Novel Computational Framework for Evaluating Transcriptional Age},
journal = {Aging Cell},
year = {2025},
volume = {24},
number = {7},
doi = {10.1111/acel.70075}
}
EUVIMED